Skip to main content

NeuroPace Inc

NPCE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001528287

No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by NeuroPace Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for NeuroPace Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for NeuroPace Inc
NameTitleLast reported holdingLast filingFilings, past year
Morrell MarthaCHIEF MEDICAL OFFICER51,357Sep 25, 202612
Williams Patrick F.Chief Financial Officer67,508Sep 21, 20262
Becker JoelCHIEF EXECUTIVE OFFICER138,000Sep 4, 20268
Fischer Frank MDirector599,534Jun 22, 20264
Geiger UriDirector18,537Jun 22, 20264
Kumar RakhiDirector23,039Jun 22, 20264
Huennekens R ScottDirector2,890Jun 5, 20261
Andrade LisaDirector2,890Jun 5, 20261
Ryan ReneeDirector2,890Jun 5, 20261
Lacob JosephDirector14,754Mar 24, 20262
Kuhn RebeccaCHIEF FINANCIAL OFFICER131,613Jun 6, 20250
OrbiMed Advisors LLC10% Owner3,238,199IndirectMay 16, 20250
OrbiMed Capital GP VI LLC10% Owner3,238,199IndirectMay 16, 20250
KCK Ltd.10% Owner0Feb 20, 20250
Ridley IrinaChief Legal Officer/Secretary141,139Feb 22, 20230
Favet MichaelChief Executive Officer407,080Feb 22, 20230
Accelmed Partners II L.P.10% Owner4,432,948Nov 23, 20220
Garfield Greg ShawDirector–Jun 21, 20220
Norton EvanDirector–Oct 8, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 4, 2026 (view filing)Dec 15, 202579 daysLateMorrell MarthaCHIEF MEDICAL OFFICERSSale−25.0K$15.97−$399.3K−33.3%50.0K after
May 16, 2025 (view filing)5:26 PM ETMay 142 daysOrbiMed Advisors LLC and 1 other10% OwnerSSale−168.1K$15.85−$2.67M−4.9%3.24M after2 lots
Feb 25, 2025 (view filing)Feb 214 daysMorrell MarthaCHIEF MEDICAL OFFICERSSale−78.3K$13.72−$1.07M−48.9%82.0K after
Feb 20, 2025 (view filing)Feb 20Same dayKCK Ltd.10% OwnerSSale−5.27M$9.40−$49.5M−100.0%0 after
Jan 31, 2025 (view filing)Jan 29-302 daysMorrell MarthaCHIEF MEDICAL OFFICERSSale−300$15.00−$4.50K−0.3%86.8K after2 lots10b5-1
Jan 28, 2025 (view filing)Jan 244 daysMorrell MarthaCHIEF MEDICAL OFFICERSSale−3.20K$15.01−$48.0K−3.5%87.1K after10b5-1
Oct 28, 2024 (view filing)Oct 23-255 daysLateKCK Ltd.10% OwnerSSale−224.1K$5.45−$1.22M−4.1%5.27M after2 lots
Oct 24, 2024 (view filing)Oct 222 daysKCK Ltd.10% OwnerSSale−4.08K$6.09−$24.9K−0.1%5.49M after
Oct 22, 2024 (view filing)Oct 18-214 daysKCK Ltd.10% OwnerSSale−8.60K$6.21−$53.4K−0.2%5.50M after2 lots
Oct 18, 2024 (view filing)Oct 3-1715 daysLateKCK Ltd.10% OwnerSSale−46.4K$6.54−$303.4K−0.8%5.51M after11 lots
Oct 3, 2024 (view filing)Aug 30-Oct 234 daysLateKCK Ltd.10% OwnerSSale−39.7K$6.92−$274.7K−0.7%5.55M after13 lots
May 3, 2024 (view filing)5:16 PM ETMay 1-32 daysOrbiMed Advisors LLC and 1 other10% OwnerSSale−29.2K$14.02−$409.4K−0.9%3.41M after3 lots
Apr 26, 2024 (view filing)5:01 PM ETApr 242 daysOrbiMed Advisors LLC and 1 other10% OwnerSSale−1.78K$14.06−$25.0K−0.1%3.44M after
Apr 23, 2024 (view filing)6:38 PM ETApr 19-234 daysOrbiMed Advisors LLC and 1 other10% OwnerSSale−64.7K$14.12−$913.1K−1.8%3.44M after3 lots
Apr 18, 2024 (view filing)5:10 PM ETApr 16-182 daysOrbiMed Advisors LLC and 1 other10% OwnerSSale−17.0K$14.02−$238.2K−0.5%3.50M after3 lots
Apr 15, 2024 (view filing)5:25 PM ETApr 11-124 daysOrbiMed Advisors LLC and 1 other10% OwnerSSale−485.0K$14.49−$7.03M−12.1%3.52M after2 lots
Feb 6, 2024 (view filing)Feb 2-54 daysMorrell MarthaChief Medical OfficerSSale−17.6K$15.09−$265.4K−18.4%77.8K after2 lots
Feb 1, 2024 (view filing)Jan 30-Feb 12 daysMorrell MarthaChief Medical OfficerSSale−13.8K$15.09−$209.0K−12.7%95.4K after3 lots
Jan 26, 2024 (view filing)Jan 24-252 daysMorrell MarthaChief Medical OfficerSSale−828$15.03−$12.4K−0.8%109.2K after2 lots
Dec 28, 2023 (view filing)Dec 26-272 daysMorrell MarthaChief Medical OfficerSSale−13.4K$10.12−$135.6K−10.9%110.0K after2 lots
Dec 22, 2023 (view filing)Dec 202 daysMorrell MarthaChief Medical OfficerSSale−2.73K$10.14−$27.7K−2.2%123.4K after
Dec 7, 2023 (view filing)Dec 61 dayMorrell MarthaChief Medical OfficerSSale−11.0K$8.16−$89.8K−8.0%126.2K after
Dec 1, 2023 (view filing)Nov 29-Dec 12 daysKCK Ltd.10% OwnerSSale−16.2K$8.78−$141.9K−0.3%5.59M after3 lots
Nov 29, 2023 (view filing)Nov 27-282 daysKCK Ltd.10% OwnerSSale−11.2K$8.87−$99.1K−0.2%5.61M after2 lots
Oct 4, 2023 (view filing)5:36 PM ETOct 2-32 daysOrbiMed Advisors LLC and 1 other10% OwnerSSale−8.31K$9.07−$75.4K−0.2%4.00M after2 lots
Nov 23, 2022 (view filing)Nov 21-222 daysAccelmed Partners II L.P.10% OwnerPPurchase+390.3K$1.50+$585.4K+9.7%4.43M after2 lots
Jun 9, 2022 (view filing)Jun 81 dayRidley IrinaGeneral Counsel and SecretarySSale−2.50K$5.78−$14.4K−3.9%61.1K after
Mar 1, 2022 (view filing)Feb 281 dayRidley IrinaGeneral Counsel and SecretarySSale−1.47K$7.54−$11.1K−18.1%6.65K after